TheBioTicker ™️💯💤

BiotechLover. Posts are my opinion. Not investment advise.

[TheBioTicker ™️💯💤 @WWokna]

despite reading someone's tweets against $PRQR, I believe it's the highest R/R out there. will be a very interesting 1H (pipes + new deals). Imho . long @RNAiAnalyst @JD4for4 @Pharmdca @biotech_cash @LTbioinvestor @Abby10Smalls @sonichedgefund

[TheBioTicker ™️💯💤 @WWokna]

Opened a new position yesterday : $CMTX good deal done , nice pipeline . Long

[TheBioTicker ™️💯💤 @WWokna]

Nice week $XBI 👀🤑 2023 portfolio : $PRQR $NLSP $ICVX $APTX $GOVX $OCUL $ANNX $XFOR 📈📈🤑

[TheBioTicker ™️💯💤 @WWokna]

@RverObs Have some faith ! 🤑🤞🏻🖖🏻 🙏🏻

[TheBioTicker ™️💯💤 @WWokna]

Next week : $PRQR 5,25$ 👀👀📈⏰🧐

[TheBioTicker ™️💯💤 @WWokna]

@Pharmdca

[BioRocket Pawcio 🚀 @pawcio2009]

Here is the updated history of #biopick winners over the years. As expected this year's winner had lowest gain %.

[Christopher @phillyrealty]

Cheers to 2023 returns ! Thank you for the mention. Some amazing names on this list 🙏🙏🙏

[TheBioTicker ™️💯💤 @WWokna]

@JD4for4 @AaronRosenblum5 @jfais20 @phillyrealty @biotech_cash @crist_phd @duikb00t @LTbioinvestor @semodough @BillMiller32 @RNAiAnalyst @pick1998_2 @BiotechCat @kios_que @cavemom11 #2023 #NewYearsDay

[TheBioTicker ™️💯💤 @WWokna]

$APTO big boys 👀👀📈📈📈⏰

[TheBioTicker ™️💯💤 @WWokna]

$AXSM 📈🖖🏻 long

[TheBioTicker ™️💯💤 @WWokna]

@avidresearch $APTO 👀👀

[dough @semodough]

$APTO Reports Results for the Third Quarter 2022 continue to see meaningful responses across dose levels and look forward to providing the full scope of blast reduction and response rate data from the Phase 1/2 trial in the #ASH22 timeframe next month.” https://t.co/oqTKQsquJw

[TheBioTicker ™️💯💤 @WWokna]

$APTO The comeback ⏰⏰

[Joe @Gantosj]

Looks like $APTO's conference call yesterday opened some investors eyes & understand the potential!

HM239 or Tuspetinib is an active drug that brings 7 CR's & 1 PR in 3 different dose levels.

Full data set at a KOL call the same day as #ASH22 conference.

[Joe @Gantosj]

@semodough $APTO is holding a private event every year post #ASH to share updated data that can't be added to the OLD ASH poster (usually 2 months before ASH)

This year they will bring in KOL - exciting!

[Seeking Alpha @SeekingAlpha]

$APTO $APS:CA - Aptose Biosciences Inc. (APTO) Q3 2022 Earnings Call Transcript. https://t.co/teezhn4GsM #stocks #investing #trading

[Joe @Gantosj]

Looks like $APTO's conference call yesterday opened some investors eyes & understand the potential!

HM239 or Tuspetinib is an active drug that brings 7 CR's & 1 PR in 3 different dose levels.

Full data set at a KOL call the same day as #ASH22 conference.

[dough @semodough]

$APTO - on earnings call - MGT definitely sounded like they have impressive data to share at ASH - tomorrow abstract just place holder - accelerated pathways ? Also possibly monetizing LUX next year- stock was basically trading at cash - good overview below what’s coming up

[TheBioTicker ™️💯💤 @WWokna]

Speculative position 4 november : #shortsqueeze $GOVX $MRKR data #covid / data #AML could be huge move. 👁👁✍🏼🤑

[TheBioTicker ™️💯💤 @WWokna]

@ANACONDAFINANC1 It ‘s time for The CEO 🤬 to Make a fair one 🫣$AFMD